1. Home
  2. LUNG vs MBOT Comparison

LUNG vs MBOT Comparison

Compare LUNG & MBOT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LUNG
  • MBOT
  • Stock Information
  • Founded
  • LUNG 1995
  • MBOT 2010
  • Country
  • LUNG United States
  • MBOT United States
  • Employees
  • LUNG N/A
  • MBOT N/A
  • Industry
  • LUNG Industrial Specialties
  • MBOT Medical/Dental Instruments
  • Sector
  • LUNG Health Care
  • MBOT Health Care
  • Exchange
  • LUNG Nasdaq
  • MBOT Nasdaq
  • Market Cap
  • LUNG 124.0M
  • MBOT 99.3M
  • IPO Year
  • LUNG 2020
  • MBOT N/A
  • Fundamental
  • Price
  • LUNG $2.67
  • MBOT $2.41
  • Analyst Decision
  • LUNG Buy
  • MBOT Strong Buy
  • Analyst Count
  • LUNG 6
  • MBOT 1
  • Target Price
  • LUNG $11.53
  • MBOT $9.00
  • AVG Volume (30 Days)
  • LUNG 366.5K
  • MBOT 1.7M
  • Earning Date
  • LUNG 07-30-2025
  • MBOT 08-13-2025
  • Dividend Yield
  • LUNG N/A
  • MBOT N/A
  • EPS Growth
  • LUNG N/A
  • MBOT N/A
  • EPS
  • LUNG N/A
  • MBOT N/A
  • Revenue
  • LUNG $87,473,000.00
  • MBOT N/A
  • Revenue This Year
  • LUNG $18.02
  • MBOT N/A
  • Revenue Next Year
  • LUNG $18.17
  • MBOT N/A
  • P/E Ratio
  • LUNG N/A
  • MBOT N/A
  • Revenue Growth
  • LUNG 19.84
  • MBOT N/A
  • 52 Week Low
  • LUNG $2.62
  • MBOT $0.82
  • 52 Week High
  • LUNG $9.37
  • MBOT $3.38
  • Technical
  • Relative Strength Index (RSI)
  • LUNG 33.53
  • MBOT 45.79
  • Support Level
  • LUNG $2.62
  • MBOT $2.33
  • Resistance Level
  • LUNG $3.52
  • MBOT $2.53
  • Average True Range (ATR)
  • LUNG 0.23
  • MBOT 0.15
  • MACD
  • LUNG 0.02
  • MBOT -0.04
  • Stochastic Oscillator
  • LUNG 13.46
  • MBOT 25.42

About LUNG Pulmonx Corporation

Pulmonx Corp is a commercial-stage medical technology company. It provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease (COPD). The company's solutions are comprised of the Zephyr Endobronchial Valve, the Chartis Pulmonary Assessment System and the StratX Lung Analysis Platform. It generates revenue through the sale of products to distributors and hospitals in the United States which a key revenue generating market, Europe, Middle-East and Africa, Asia Pacific and other regions.

About MBOT Microbot Medical Inc.

Microbot Medical Inc is a clinical-stage medical device company specializing in the research, design and development of next-generation robotic endoluminal surgery devices targeting the minimally invasive surgery space. It is focused on leveraging its robotic technologies to redefine surgical robotics while improving surgical outcomes for patients. Using its LIBERTY technological platform, the company is developing the first-ever fully disposable robot for various endovascular interventional procedures.

Share on Social Networks: